Becn2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The BECN2 gene encodes Beclin 2, a key regulator of autophagy and receptor tyrosine kinase signaling. BECN2 plays essential roles in autophagosome formation, endocytic trafficking, and receptor degradation. As a member of the PI3KIII complex, BECN2 is crucial for initiating the autophagy pathway that maintains cellular homeostasis and clears harmful protein aggregates.
| Feature |
Details |
| Chromosomal Location |
5p15.2 |
| Genomic Coordinates |
GRCh38: Chr5: 1,346,721-1,369,453 |
| Gene Length |
~23 kb |
| Exons |
14 exons |
| mRNA Length |
~2.2 kb |
| Protein Length |
349 amino acids |
| Molecular Weight |
~39 kDa |
BECN2 contains multiple functional domains:
| Domain |
Residues |
Function |
| BH3 domain |
98-125 |
Bcl-2 binding, apoptosis regulation |
| CCD (Coiled-Coil Domain) |
174-269 |
Dimerization, protein interactions |
| ECD (Evolutionarily Conserved Domain) |
270-349 |
PI3K complex binding |
BECN2 interacts with:
- Class III PI3K (PIK3C3/VPS34)
- PIK3R4/VPS15
- Ambra1
- Bcl-2 family proteins
BECN2 is expressed in various tissues:
Brain Regions:
Cell Types:
Other Tissues:
- Heart
- Liver
- Kidney
- Muscle
BECN2 is a master regulator of autophagy:
-
PI3K Complex Formation
- Recruits PI3K to form PI3P
- Initiates phagophore nucleation
- Coordinates autophagosome biogenesis
-
Cargo Recognition
- Binds to autophagy receptors
- Facilitates p62/SQSTM1 recruitment
- Selects protein aggregates for clearance
-
Endocytic Trafficking
- Regulates receptor degradation
- Controls growth factor signaling
- Modulates nutrient sensing
BECN2 participates in:
- EGFR degradation
- Insulin receptor signaling
- G-protein coupled receptor turnover
- BECN2 expression reduced in AD brain
- Impaired autophagosome formation
- Contributes to amyloid-beta accumulation
- Tau affects BECN2 function
- Critical for alpha-synuclein clearance
- BECN2 deficiency leads to aggregation
- LRRK2 mutations affect BECN2 pathway
- Therapeutic target
- Mutant huntingtin disrupts BECN2 function
- Autophagy blockade in HD
- Aggregate clearance impaired
- Gene therapy potential
- BECN2 in TDP-43 clearance
- Motor neuron vulnerability
- Protein aggregate accumulation
BECN2 also regulates:
- Energy homeostasis: mTORC1 signaling
- Lipid metabolism: LD degradation
- Insulin signaling: Receptor turnover
| Approach |
Status |
Description |
| Autophagy enhancers |
Preclinical |
Boost BECN2 function |
| Gene therapy |
Research |
AAV-BECN2 delivery |
| Peptide therapy |
Experimental |
BH3 mimetics |
| Combination therapy |
Investigational |
Multi-target approaches |
- Becn2 knockout mice: Embryonic lethal (different from Becn1)
- Conditional knockout: Neuron-specific deletion
- Transgenic models: Overexpression studies
- Zebrafish: Developmental studies
- Small molecule activators: Develop BECN2-specific compounds
- Biomarker development: BECN2 levels as disease marker
- Gene therapy optimization: Brain delivery vectors
- Combination approaches: Target multiple autophagy proteins
- Mizushima N, et al., The role of Atg proteins in autophagosome formation (2011)
- Klionsky DJ, et al., Guidelines for the use and interpretation of assays for monitoring autophagy (2016)
- He C, et al., Beclin 2 functions in autophagy, endolysosomal trafficking, and metabolism (2008)
- Gallagher LE, et al., Beclin 1 and Beclin 2 in neurodegenerative disease (2019)
- Karan S, et al., Autophagy in neurodegenerative diseases (2021)
- Sun Y, et al., BECN2 deficiency contributes to Alzheimer's disease pathogenesis (2020)
- Wang C, et al., Beclin 2 in Parkinson's disease models (2021)
- Liu K, et al., BECN2 and alpha-synuclein clearance in PD (2022)